| Hans-Günter Meyer-Thompson | Hepatitiden
Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting.
Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting.
Yela E, Solé N, Puig L, López Gallegos D, Clua-García R.
Harm Reduct J. 2024 Apr 27;21(1):88. doi: 10.1186/s12954-024-01009-7. PMID: 38678266; PMCID: PMC11055286.